First Allied Advisory Services Inc. cut its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 1.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,120 shares of the medical equipment provider’s stock after selling 127 shares during the quarter. First Allied Advisory Services Inc.’s holdings in Zimmer Biomet Holdings were worth $908,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in ZBH. BlackRock Inc. boosted its stake in Zimmer Biomet Holdings by 4.1% during the 2nd quarter. BlackRock Inc. now owns 17,419,463 shares of the medical equipment provider’s stock worth $2,236,657,000 after acquiring an additional 679,080 shares during the last quarter. Vanguard Group Inc. increased its stake in Zimmer Biomet Holdings by 2.6% in the second quarter. Vanguard Group Inc. now owns 13,380,517 shares of the medical equipment provider’s stock valued at $1,718,057,000 after purchasing an additional 339,106 shares in the last quarter. State Street Corp increased its stake in Zimmer Biomet Holdings by 2.4% in the first quarter. State Street Corp now owns 8,193,165 shares of the medical equipment provider’s stock valued at $1,000,463,000 after purchasing an additional 191,747 shares in the last quarter. Longview Partners Guernsey LTD increased its stake in Zimmer Biomet Holdings by 4.4% in the second quarter. Longview Partners Guernsey LTD now owns 6,377,711 shares of the medical equipment provider’s stock valued at $818,898,000 after purchasing an additional 269,184 shares in the last quarter. Finally, Nordea Investment Management AB increased its stake in Zimmer Biomet Holdings by 25.0% in the first quarter. Nordea Investment Management AB now owns 4,931,281 shares of the medical equipment provider’s stock valued at $602,159,000 after purchasing an additional 987,398 shares in the last quarter. 85.36% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: “First Allied Advisory Services Inc. Has $908,000 Stake in Zimmer Biomet Holdings, Inc. (ZBH)” was posted by Watch List News and is the property of of Watch List News. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.watchlistnews.com/first-allied-advisory-services-inc-has-908000-stake-in-zimmer-biomet-holdings-inc-zbh/1605367.html.

Shares of Zimmer Biomet Holdings, Inc. (NYSE ZBH) traded down 0.01% during midday trading on Tuesday, reaching $117.69. 25,308 shares of the company traded hands. The company has a 50-day moving average of $114.48 and a 200 day moving average of $120.54. Zimmer Biomet Holdings, Inc. has a 12-month low of $95.63 and a 12-month high of $133.49. The firm has a market capitalization of $23.80 billion, a PE ratio of 33.52 and a beta of 1.19.

Zimmer Biomet Holdings (NYSE:ZBH) last issued its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing the Zacks’ consensus estimate of $2.10 by ($0.02). The business had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.95 billion. Zimmer Biomet Holdings had a net margin of 9.12% and a return on equity of 16.70%. The business’s revenue was up 1.1% compared to the same quarter last year. During the same period in the previous year, the business posted $2.02 earnings per share. On average, equities analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 22nd will be paid a $0.24 dividend. The ex-dividend date of this dividend is Thursday, September 21st. This represents a $0.96 dividend on an annualized basis and a yield of 0.82%. Zimmer Biomet Holdings’s dividend payout ratio (DPR) is presently 27.59%.

In other news, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction on Monday, July 31st. The stock was sold at an average price of $121.74, for a total transaction of $2,067,875.64. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 1.07% of the company’s stock.

A number of analysts recently commented on the stock. Zacks Investment Research cut shares of Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a research report on Tuesday, July 4th. BMO Capital Markets reiterated a “buy” rating and set a $136.00 target price on shares of Zimmer Biomet Holdings in a report on Tuesday, July 11th. Wells Fargo & Company reissued a “market weight” rating on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Morgan Stanley increased their price target on Zimmer Biomet Holdings from $137.00 to $150.00 and gave the stock an “overweight” rating in a report on Monday, July 17th. Finally, Stifel Nicolaus restated a “hold” rating and issued a $125.00 price target on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. Zimmer Biomet Holdings presently has an average rating of “Hold” and an average price target of $136.55.

Zimmer Biomet Holdings Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.